Nevrargenics is a drug discovery and development company working towards understanding, treating and reversing neurodegenerative diseases. Our interests are widely across neurodegenerative diseases through a novel dual-acting small molecule, which may be valuable in treating a number of closely linked diseases, such as ALS, FTD and Alzheimer's disease.